SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022685
Filing Date
2024-04-29
Accepted
2024-04-29 07:06:20
Documents
5
Period of Report
2024-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20022238x2_def14a.htm DEF 14A 690270
2 ny20022238x2_pc01.jpg GRAPHIC 623024
3 ny20022238x2_pc02.jpg GRAPHIC 391005
4 ny20022238x2_pvp01.jpg GRAPHIC 105412
5 ny20022238x2_pvp02.jpg GRAPHIC 101056
  Complete submission text file 0001140361-24-022685.txt   2371217
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37568 | Film No.: 24886562
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)